Sign in to view content

Visual Loss After Cosmetic Facial Filler Injection

Min Kim, MD, PhD, MBA, FASRS

Video
Published 2016

Related

“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity
Thomas A. Ciulla, MD, MBA, FASRS
Annual Meeting Talks
2016
Randomized, Prospective Study of Aflibercept for Visually Significant Radiation Maculopathy - Interim Analysis
Timothy G. Murray, MD, MBA, FASRS
Annual Meeting Talks
2016
ORBIT: A Phase IV Clinical Study - Lessons Learned From Patient Selection Criteria for Ocriplasmin Intravitreal Injection
Mathew W. MacCumber, MD, PhD
Annual Meeting Talks
2016

Category: Retinal Vascular Disease

See more